Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

RNA immunity is a defense system against viruses, including the cross-species regulation of exogenous miRNAs and the endogenous RNA-based immune system. Figure created with BioRender.com. Conventional ...

Distinct patterns of SARS-CoV-2 viral dynamics in saliva reveal heterogeneity that cannot be sufficiently explained by conventional clinical characteristics or microRNA profiles alone.

Mammalian immunity has long been thought to rely solely on proteins and specialized immune cells. However, a newly proposed concept—RNA immunity—is reshaping this perspective. In a recent publication ...